Gefticip 250mg Tablet 30’s

Name: Buy Gefticip 250mg Tablet 30's Online: Cheapest Price, Uses.
Price: 3250.00 INR
Availability: InStock

Original price was: ₹5,491.42.Current price is: ₹3,250.00.

Prescription Required

Salt : Gefitinib

Manufacturer : CIPLA LTD

Packing : 30 Tablet(S) In A Bottle

Compare

Add to wishlist

Categories: All Products, Lung

Description

PRODUCT INTRODUCTION

Gefticip 250mg Tablet 30’s is a medication primarily used in the treatment of non-small cell lung cancer (NSCLC). It contains the active ingredient Gefitinib, which belongs to a class of medications known as tyrosine kinase inhibitors. Gefticip works by inhibiting the action of specific proteins involved in the growth and spread of cancer cells, thereby slowing down or stopping the progression of the disease.

USES OF Gefticip 250mg Tablet 30’s

Gefticip 250mg Tablet 30’s is prescribed for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have specific mutations in the epidermal growth factor receptor (EGFR) gene. It is typically used when other treatments have not been effective or when the cancer has progressed despite other therapies.

BENEFITS OF Gefticip 250mg Tablet 30’s

The primary benefit of Gefticip 250mg Tablet 30’s is its ability to effectively target and inhibit the growth of cancer cells in patients with advanced or metastatic NSCLC who have EGFR mutations. By blocking the activity of EGFR, Gefticip helps to slow down the progression of the disease, alleviate symptoms, and improve overall survival rates. Additionally, Gefticip is administered orally, making it convenient for patients to take at home.

SIDE EFFECTS OF Gefticip 250mg Tablet 30’s

While Gefticip is generally well-tolerated, it may cause some side effects in some individuals. Common side effects include diarrhea, rash, acne, dry skin, nausea, vomiting, loss of appetite, and fatigue. Some patients may also experience more serious side effects such as liver problems, interstitial lung disease (ILD), and gastrointestinal perforation, although these are rare. It is essential for patients to promptly report any adverse reactions to their healthcare provider for proper management.

References

Chabner BA, Barnes J, Neal J, et al. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1734-35.
Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 954-55.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 616-17.
Gefitinib. Luton, Bedfordshire: AstraZeneca UK Limited; 2009 [revised 23 Apr. 2018]. [Accessed 232 Jan. 2019] (online) Available from:
Drugs.com. Gefitinib Pregnancy and Breastfeeding Warnings. [Accessed 27 Mar. 2019] (online) Available from:
Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Gefitinib. [Updated 2018 Dec 3]. [Accessed 18 Feb. 2020] (online) Available from:
Central Drugs Standard Control Organisation (CDSCO). [Accessed 27 Mar. 2019] (online) Available from:

Disclaimer

Singhla Medicos’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Singhla Medicos. Our mission is to support, not replace, the doctor-patient relationship.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Gefticip 250mg Tablet 30’s”

Shipping & Delivery

Shipping Policy

We ship across India. Note – this is subject to change as per Company Wishes. Packages will be shipped in 24 working hours. we are closed on Sundays and will reach you in the next 2-4 days post shipping. We give the estimated time of delivery on the shipping page. However, these are indicative and depend on our shipping partner.

Delivery

The delivery times are subject to location, distance, and our logistics partners. We are not liable for any delays in delivery by the courier company/postal authorities but will help you track down a package through our partner courier services.

Your purchases may reach you from various locations in more than one package. But rest assured, you will be charged one delivery fee for the entire order. As soon as your package ships, we will email you your package tracking information.

We are bound in coverage by their reach even though we use some of India’s largest logistics companies for shipping. In case your address is in a location not served by them we would contact you to find an alternative solution to make your products reach you.

Gefticip 250mg Tablet 30’s

PRODUCT INTRODUCTION

USES OF Gefticip 250mg Tablet 30’s

BENEFITS OF Gefticip 250mg Tablet 30’s